Narayana Hrudayalaya Ltd. (NH) fair value: what the stock is really worth
As of Sep 23, 2026: fair value of Narayana Hrudayalaya Ltd. ₹1,310, price ₹1,919, upside -31.7%, quality 52 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Narayana Hrudayalaya Ltd. for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range ₹354.79 – ₹2,258 · fair‑value band ₹661.52 – ₹2,356 · the ₹1,919 price screens above the ₹1,310 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.
Follow Narayana Hrudayalaya in your weekly email
Every Wednesday you see whether Narayana Hrudayalaya is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Narayana Hrudayalaya Limited provides medical and healthcare services in India and the Cayman Islands. It operates through the Medical and Healthcare Related Services; and Others segments.
Show more
Narayana Hrudayalaya Limited provides medical and healthcare services in India and the Cayman Islands. It operates through the Medical and Healthcare Related Services; and Others segments. The company offers oncology, anesthesiology, audiology, blood bank, oncoplastic surgery, cardiac surgery, cardiology, clinical genetics, clinical immunology, clinical nutrition and dietetics, clinical psychology, congenital adult heart disease, cosmetology, cranio-maxillofacial surgery, critical care medicine, dental, dermatology, pediatrics, diabetology, ENT, emergency medicine, endocrinology, family medicine, general and GI surgery, general medicine and surgery, geriatric medicine, gynecology, hematology, headache and facial pain management, transplant, infectious diseases, neurology, radiology, hepatobiliary surgery, gastroenterology, minimal access GI and bariatric surgery, neonatology, nephrology, neuro-otology, neuro-rehabilitation, neurosurgery and spine surgery, and nuclear medicine services. It also provides ophthalmology, orthopedics and joint replacement, pain management and palliative care, pathology, perinatology and fetal intervention, physical medicine and rehabilitation, physiotherapy and physical rehabilitation, plastic surgery, psychiatry, pulmonology, reproductive medicine, rheumatology, renal science, speech and swallow rehabilitation, spine surgery, thoracic and vascular surgery, ultrasonology, urology, and other services. In addition, the company acquires, owns, and operates hospitals, clinics, health centers, diagnostic centers, and nursing homes. Further, it provides health insurance, consultancy services in the field of healthcare and hospitals, and IT services related to healthcare. Additionally, the company engages in investment activities; and develops software related to the healthcare industry. Narayana Hrudayalaya Limited was incorporated in 2000 and is headquartered in Bengaluru, India.
Stock analysis
Narayana Hrudayalaya Ltd. (NH) currently trades at ₹1,919, while our model-based Fair Value estimate is ₹1,310, implying the stock looks roughly 46.5% overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ₹1,113 per share, and 0 of the 26 models we run sit above the ₹1,919 price.
Bear case: the Asset-Based group reads lowest at ₹149.68, and 26 of the 26 models stay below the price. Evidence for this calculation is medium.
Scenario range: ₹661.52 (bear) to ₹2,356 (bull), the price of ₹1,919 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 52/100 (solid quality), in the Healthcare sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Narayana Hrudayalaya Ltd. reported revenue of ₹79.0B in FY2026 versus ₹37.0B in FY2022, a compound +20.9%/yr. Reported net income was ₹8.1B in FY2026, compounding +23.9%/yr from FY2022.
Key figures
Market cap ₹390B (≈ $4.1B) · P/E ratio 48.1 · P/S ratio 4.90 · EPS (TTM) ₹39.94 · Dividend yield 0.2% · Net margin 10.2% · Return on equity 19.9% · Return on assets (EBIT) 26.8%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 51 out of 100 (low confidence).
What moves the price
The share trades about 8% below its 52-week high and 20% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 35% fair-value upside, at −32%, NH screens richer than that median.
Fair Value models
Bear ₹661.52Fair Value ₹1,310Bull ₹2,356
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2026 figures (about 6 months old). Earnings retained since then (₹17.19 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.95/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+44.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+20.4%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+25.0%
Start year 2021 (pandemic). Over 10 years: +17.2% a year
Revenue growth 15 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+20.6%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
’26
What shareholders gained per year (last 5 years), in INR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+28.6%
Earnings growth per share plus dividend.
Earnings per share, growth per year+28.4%
Dividend (yield on the price)0.2%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.28% vs 32%, slowing
Profit margin 2011 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.5% → 15%
Start year 2021 (pandemic)
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+36.7%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+14.5%
Yearly sales growth analysts expect, extended to five years.
After inflation (India: IMF forecast 4.1% a year to 2030, 4.7% from 2016 to 2025) that is about +31.3% a year for the price and +9.9% for the forecasts.
Compare Narayana Hrudayalaya Ltd. with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 257 stocks
Beats the industry median on 6/14 measures
A mixed picture versus its industry peers.
Valuation
Quality Score52 · Below median
Fair Value upside−32% · Below median
Profitability
Return on equity (TTM)20% · Top 25%
Return on assets7% · Top 25%
Net margin (TTM)10% · Above median
Operating margin (TTM)14% · Above median
Growth and dividend
Revenue growth76% · Top 25%
Dividend yield (TTM)0.2% · Bottom 25%
Balance sheet
Debt / equity1.03× · Highest 25%
Valuation Multiplesvs Medical Care Facilities median · lower = cheaper
P/E (TTM)48.1× · Priciest 25%
P/B8.59× · Priciest 25%
P/S (TTM)4.94× · Priciest 25%
P/FCF0.7× · Cheaper than median
EV/EBITDA26.5× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 33
FUTURE (revenue growth)100· sector 29
PAST (return on equity)79· sector 31
HEALTH (low debt)49· sector 89
DIVIDEND (yield)5· sector 42
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Narayana Hrudayalaya Ltd. (NH) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of ₹1,310 versus a price of ₹1,919, about −32% upside (overvalued).
What is the fair value of NH?
Our model-based fair value for Narayana Hrudayalaya Ltd. is ₹1,310 (as of Sep 24, 2026), built from audited fundamentals. The current price: ₹1,919.
What is the quality score of NH?
Narayana Hrudayalaya Ltd. has a Quality Score of 52/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Narayana Hrudayalaya Ltd. (NH)?
Our model-based price target is the fair value of ₹1,310 (as of Sep 24, 2026) from 26 valuation models. Cautious scenario ₹661.52, optimistic scenario ₹2,356. It is a calculation from audited fundamentals, not an analyst target.
What is the Narayana Hrudayalaya Ltd. stock forecast for 2026?
Our models put fair value at ₹1,310, about −32% upside versus a price of ₹1,919 (overvalued). Cautious scenario ₹661.52, optimistic scenario ₹2,356. The calculation is refreshed regularly with new filings.
What is the revenue of Narayana Hrudayalaya Ltd. (NH)?
Narayana Hrudayalaya Ltd. reported trailing-twelve-month revenue of about ₹79.0B (latest available figure, as of Sep 24, 2026).
Does Narayana Hrudayalaya Ltd. pay a dividend?
Narayana Hrudayalaya Ltd. currently shows a dividend yield of about 0.23% relative to its recent price (as of Sep 24, 2026).
What growth is priced into Narayana Hrudayalaya Ltd. (NH)?
For today's price to be fair in a discounted-cash-flow model, Narayana Hrudayalaya Ltd. would have to grow free cash flow by +36.7 % per year for five years (discount rate 10.9 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +25.0 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of NH use?
Our models discount Narayana Hrudayalaya Ltd. at 10.9 %: a base by market capitalisation (mid), damped by beta 0.18, country premium for India. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Narayana Hrudayalaya Ltd. that is +36.7 % per year a year over ten years, using the same discount rate (10.9 %) and the same formula as our fair value.
How much growth has Narayana Hrudayalaya Ltd. (NH) delivered so far?
Over the past 5 years revenue at Narayana Hrudayalaya Ltd. grew +25.0 % a year. The price currently implies +36.7 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Narayana Hrudayalaya Ltd. (NH) growing?
The median revenue growth in the sector is +4.2 % a year. That is the yardstick for the growth priced into Narayana Hrudayalaya Ltd. (+36.7 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Narayana Hrudayalaya Ltd. (NH)?
The free-cash-flow yield on the price is 1.54 %: that much free cash flow Narayana Hrudayalaya Ltd. produces per unit of market value. When it exceeds the discount rate of our models (10.9 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Narayana Hrudayalaya Ltd. (NH)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Narayana Hrudayalaya Ltd. it is ₹1,310 per share (as of Sep 24, 2026), against a price of ₹1,919. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is Narayana Hrudayalaya Ltd. stock overvalued or undervalued in 2026?
As of Sep 24, 2026, NH trades above its calculated fair value: price ₹1,919, fair value ₹1,310, a gap of about −32% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of NH?
No. The price is what the market pays today (₹1,919); the fair value is what the company's own numbers justify (₹1,310). For Narayana Hrudayalaya Ltd. the two are ₹609.10 per share apart. That gap is exactly why we show both numbers side by side.
How much is Narayana Hrudayalaya Ltd. worth?
The market values Narayana Hrudayalaya Ltd. at about ₹390B (market capitalisation, as of Sep 24, 2026). Per share that is ₹1,919; our models calculate a fair value of ₹1,310 per share.
What do the bullish and bearish scenarios say about NH?
Our models span a range for Narayana Hrudayalaya Ltd.: cautious scenario ₹661.52, base ₹1,310, optimistic ₹2,356 per share (as of Sep 24, 2026, price ₹1,919). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of NH?
Narayana Hrudayalaya Ltd. trades at a price-to-earnings ratio of 48.1 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹1,310 is built from several models across several years. Other multiples: P/B 8.6, P/S 4.9, EV/EBITDA 26.5.
How solid is the balance sheet of Narayana Hrudayalaya Ltd. (NH)?
Balance-sheet figures for Narayana Hrudayalaya Ltd. (as of Sep 24, 2026): return on equity 19.9%, debt of 1.03 per unit of equity. They feed the Quality Score of 52/100, which measures business quality independently of the share price.
How far is NH from its 52-week high?
Narayana Hrudayalaya Ltd. trades at ₹1,919, about 8% below its 52-week high of ₹2,080 and 20% above the low of ₹1,605 (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of ₹1,310 is for.
Which stocks are comparable to Narayana Hrudayalaya Ltd.?
From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Dr. Sulaiman Al Habib Medical Services Group, IHH Healthcare Berhad, an investment holding company,, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Narayana Hrudayalaya Ltd. stock attractive at the current price?
The data as of Sep 24, 2026: price ₹1,919, calculated fair value ₹1,310 (−32%), Quality Score 52/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of NH calculated?
We run Narayana Hrudayalaya Ltd. through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ₹1,310, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. Narayana Hrudayalaya Ltd. itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Narayana Hrudayalaya Ltd. (NH)?
The closing price on Sep 23, 2026 was ₹1,919. Our model-based fair value is ₹1,310, about −32% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Narayana Hrudayalaya Ltd. right now?
The model range is unusually wide (₹661.52 to ₹2,356). The outcome hinges heavily on assumptions, so read the point estimate with caution. Solid but not exceptional quality (52/100) and above fair value, neither a clear bargain nor a standout compounder.
Where does the earnings growth of Narayana Hrudayalaya Ltd. (NH) come from?
Earnings per share at Narayana Hrudayalaya Ltd. grew +37.8 % a year from 2016 to 2026. Broken into its drivers: revenue per share +15.8 %, EBIT margin −3.5 %, tax rate +5.2 %, residual (interest, one-offs) +17.3 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Narayana Hrudayalaya Ltd.
How large is the market capitalisation of Narayana Hrudayalaya Ltd. (NH)?
The market capitalisation of Narayana Hrudayalaya Ltd. is ₹390B (≈ $4.1B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Narayana Hrudayalaya Ltd. (NH)?
The price-to-sales ratio of Narayana Hrudayalaya Ltd. is 4.90 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Narayana Hrudayalaya Ltd. (NH)?
Earnings per share at Narayana Hrudayalaya Ltd. are ₹39.94 (price ÷ EPS = P/E 48.1). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Narayana Hrudayalaya Ltd. (NH)?
The dividend yield of Narayana Hrudayalaya Ltd. is 0.2% (payout 11.3%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Narayana Hrudayalaya Ltd. (NH)?
The net margin of Narayana Hrudayalaya Ltd. is 10.2% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Narayana Hrudayalaya Ltd. (NH)?
The return on equity (ROE) of Narayana Hrudayalaya Ltd. is 19.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Narayana Hrudayalaya Ltd. (NH)?
On an EBIT basis the return on assets of Narayana Hrudayalaya Ltd. is 26.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Narayana Hrudayalaya Ltd. (NH)?
The operating margin of Narayana Hrudayalaya Ltd. is 13.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Narayana Hrudayalaya Ltd. (NH)?
Revenue at Narayana Hrudayalaya Ltd. is growing +75.8% versus a year earlier (3y avg +20.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Narayana Hrudayalaya Ltd. (NH)?
Earnings per share at Narayana Hrudayalaya Ltd. are growing +13.5% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Narayana Hrudayalaya Ltd. (NH) carry?
The net debt of Narayana Hrudayalaya Ltd. is ₹50.9B (fiscal year 2026, ≈ 8.5 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Narayana Hrudayalaya Ltd. in the live analysis
One click puts Narayana Hrudayalaya Ltd. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
